Company profile
Henan Genuine Biotech
Privately held: no public share price
Assets
(4 total)
4Total Assets
0Approved
1Phase 3 / Filed
3Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
Azvudine(FNC) | Phase 3 | HIV reverse transcriptaseSmall molecule | HIV |
| Phase 2 | HIV reverse transcriptaseSmall molecule | HIV | |
| Phase 1/2 | EGFRSmall molecule | Non-Small Cell Lung Cancer | |
| Phase 1/2 | Undisclosed / early pipelineSmall molecule | Non-Small Cell Lung Cancer |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.